NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE248053 Query DataSets for GSE248053
Status Public on Dec 01, 2024
Title Glucocorticoid- and Pioglitazone-Induced Proteinuria Reduction in Experimental Nephrotic Syndrome Both Correlate with Glomerular ECM Modulation
Organism Rattus norvegicus
Experiment type Expression profiling by high throughput sequencing
Summary Idiopathic nephrotic Syndrome (NS) is a common glomerular disease. While glucocorticoids (GC) are the primary treatment, the PPARĪ³ agonist pioglitazone (Pio) also reduces proteinuria in patients with NS and directly protects podocytes from injury. Since both drugs reduce proteinuria, we hypothesized these effects result from overlapping transcriptional patterns. Systems biology approaches compared glomerular transcriptomes from rats with PAN-induced NS treated with GC vs. Pio and identified 29 commonly regulated genes-of-interest, primarily involved in extracellular matrix (ECM) remodeling. Correlation with clinical idiopathic NS patient datasets confirmed glomerular ECM dysregulation as a potential mechanism of injury. Cellular deconvolution in silico revealed GC- and Pio-induced amelioration of altered genes primarily within podocytes and mesangial cells. While validation studies are indicated, these analyses identified molecular pathways involved in the early stages of NS (prior to scarring) suggesting that targeting glomerular ECM dysregulation may enable a future non-immunosuppressive approach for proteinuria reduction in idiopathic NS.
 
Overall design Day 11 glomeruli were isolated from rats with PAN-induced NS treated with methylprednisolone or with pioglitazone. Sham treated health controls were included as reference. N=4 rats were used for RNAseq. Data were analyzed for PAN-induced changes in gene expression and amelioration of said alterations by either drug. This study focused on the overlapping amerliorations of disease-induced gene expression between methylprednisolone and pioglitazone.
 
Contributor(s) Bhayan S, Dougherty JA, Kamigaki Y, Agrawal S, Wijeratne S, Fitch J, Waller AP, Wolfgang KJ, White P, Kerlin BA, Smoyer WE
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Nov 16, 2023
Last update date Dec 02, 2024
Contact name William E Smoyer
E-mail(s) [email protected]
Organization name Nationwide Children's Hospital, Columbus, Ohio
Department Research
Lab Smoyer
Street address 700 Children's Dr, Research Building 2
City Columbus
State/province OH
ZIP/Postal code 43205
Country USA
 
Platforms (1)
GPL22396 Illumina HiSeq 4000 (Rattus norvegicus)
Samples (16)
GSM7905279 Sham Control, rep1
GSM7905280 Sham Control, rep2
GSM7905281 Sham Control, rep3
Relations
BioProject PRJNA1041459

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE248053_AllData_160322_RNASeq_Smoyer_Results_iScience.xlsx 11.3 Mb (ftp)(http) XLSX
GSE248053_RAW.tar 2.1 Mb (http)(custom) TAR (of COV)
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap